Prediabetic changes in gene expression induced by aspartame and monosodium glutamate in Trans fat-fed C57Bl/6 J mice

Nutrition and Metabolism

Volumn 10, Issue 1, 2013, Pages

  Collison, Kate S ^a   Makhoul, Nadine J ^a   Zaidi, Marya Z ^a   Inglis, Angela ^a   Andres, Bernard L ^a   Ubungen, Rosario ^a   Saleh, Soad ^a   Al Mohanna, Futwan A ^a,b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Adipose; Aspartame; Gene expression; Liver; Metabolic dysregulation; Monosodium glutamate; Nutrigenomics; Trans hydrogenated fat

Indexed keywords

AMYLIN; ASPARTAME; C PEPTIDE; CHOLESTEROL; FOOD ADDITIVE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; GLUTAMATE SODIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN; TRANS FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; LIVER; MOUSE; NONHUMAN; OBESITY;

ANIMALIA; MUS;

EID: 84879062367     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-10-44     Document Type: Article

References (65)

1. Hepatic steatosis and morbid obesity. Ramsey-Stuart G, Obes Surg 1993 3 2 157 159 10.1381/096089293765559502 10757912 (Pubitemid 23149546)
2. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Li Z, Soloski MJ, Diehl AM, Hepatology 2005 42 4 880 885 10.1002/hep.20826 16175608 (Pubitemid 41401126)
3. Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55. Collison KS, Saleh SM, Bakheet RH, Al-Rabiah RK, Inglis AL, Makhoul NJ, Maqbool ZM, Zaidi MZ, Al-Johi MA, Al-Mohanna FA, Obesity (Silver Spring) 2009 17 11 2003 2013 10.1038/oby.2009.58
4. Time course of the development of non-alcoholic hepatic steatosis in response to high-fat diet-induced obesity in rats. Gauthier MS, Favier R, Lavoie JM, Br J Nutr 2006 95 2 273 281 10.1079/BJN20051635 16469142
5. Trans fat intake in children: risks and recommendations. Bauer LR, Waldrop J, Pediatr Nurs 2009 35 6 346 351 20166463
6. Fatty acids: are the effects only marginal? Willett WC, Ascherio A, Am J Public Health 1995 85 3 411 412 10.2105/AJPH.85.3.411 7892934
7. Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys. Kavanagh K, Jones KL, Sawyer J, Kelley K, Carr JJ, Wagner JD, Rudel LL, Obesity 2007 15 1675 1684 10.1038/oby.2007.200 17636085 (Pubitemid 47264946)
8. Metabolic implications of dietary trans-fatty acids. Dorfman SE, Laurent D, Gounarides JS, Li X, Mullarkey TL, Rocheford EC, Sari-Sarraf F, Hirsch EA, Hughes TE, Commerford SR, Obesity (Silver Spring) 2009 17 6 1200 1207
9. Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease. Collison KS, Maqbool Z, Saleh SM, Inglis A, Makhoul NJ, Bakheet R, Al-Johi M, Al-Rabiah R, Zaidi MZ, Al-Mohanna FA, J Lipid Res 2009 50 8 1521 1537 10.1194/jlr.M800418-JLR200 19001666
10. Food ingredients and colors. International Food Information Council (IFIC) and U.S. Food and Drug Administration 2004 revised April 2010 in: http://www.fda.gov/Food/IngredientsPackagingLabeling/FoodAdditivesIngredients/ ucm094211.htm
11. Umami: a delicious flavor formed by convergence of taste and olfactory pathways in the human brain. McCabe C, Rolls ET, Eur J Neurosci 2007 25 6 1855 1864 10.1111/j.1460-9568.2007.05445.x 17432971 (Pubitemid 46550014)
12. Possible neurologic effects of aspartame, a widely used food additive. Maher TJ, Wurtman RJ, Environ Health Perspect 1987 75 53 57 3319565 (Pubitemid 18061023)
13. Components of hypothalamic obesity: bipiperidyl-mustard lesions add hyperphagia to monosodium glutamate-induced hyperinsulinemia. Scalett AC, Onney JW, Brain Res 1986 374 2 380 384 10.1016/0006-8993(86)90434-8 3459567 (Pubitemid 16077991)
14. Models of neuroendocrine regulation: use of monosodium glutamate as an investigational tool. Nemeroff CB, Lipton MA, Kizer JS, Dev Neurosci 1978 1 2 102 109 10.1159/000112561 39735 (Pubitemid 9080559)
15. Late effects of postnatal administration of monosodium glutamate on insulin action in adult rats. Macho L, Ficková M, Jezová Zórad S, Physiol Res 2000 49 Suppl 1 79 S85 10984075
16. Regulation of the central nervous system-pituitary-adrenal axis in rats after neonatal treatment with monosodium glutamate. Magariños AM, Estivariz F, Morado MI, De Nicola AF, Neuroendocrinology 1988 48 2 105 111 10.1159/000124997 2851747
17. Effect of monosodium glutamate given orally on appetite control (a new theory for the obesity epidemic). Fernandez-Tresguerres Hernández JA, An R Acad Nac Med (Madr) 2005 122 2 341 355
18. Obesity, voracity, and short stature: the impact of glutamate on the regulation of appetite. Hermanussen M, García AP, Sunder M, Voigt M, Salazar V, Tresguerres JA, Eur J Clin Nut 2006 60 1 25 31 10.1038/sj.ejcn. 1602263 (Pubitemid 43731071)
19. Effect of oral administration of monosodium glutamate during pregnancy and breast-feeding in the offspring of pregnant Wistar rats. von Diemen V, Trindade MRM, Acta Cirurg Brasil 2006 25 1 37 42
20. Effects of maternal oral administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain. Yu T, Zhao Y, Shi W, Ma R, Yu L, Brain Res 1997 747 2 195 206 10.1016/S0006-8993(96)01181-X 9045994 (Pubitemid 27077393)
21. Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. Nakanishi Y, Tsuneyama K, Fujimoto M, Salunga TL, Nomoto K, An JL, Takano Y, Iizuka S, Nagata M, Suzuki W, Shimada T, Aburada M, Nakano M, Selmi C, Gershwin ME, J Autoimmun 2008 30 1-2 42 50 18178378
22. PGC-1 coactivators in the control of energy metabolism. Liu C, Lin JD, Acta Biochim Biophys Sin (Shanghai). 2011 43 4 248 257 10.1093/abbs/gmr007 21325336
23. Direct and indirect cellular effects of aspartame on the brain. Humphries P, Pretorius E, Naude H, Eur J Clin Nutr 2008 62 451 462 10.1038/sj.ejcn. 1602866 17684524
24. Effect of long term intake of aspartame on antioxidant defense status in liver. Abhilash M, Paul MV, Varghese MV, Nair RH, Food Chem Toxicol 2011 49 6 1203 1207 10.1016/j.fct.2011.02.019 21376768
25. Interactive effects of neonatal exposure to monosodium glutamate and aspartame on glucose homeostasis. Collison KS, Makhoul NJ, Zaidi MZ, Al-Rabiah R, Inglis A, Andres BL, Ubungen R, Shoukri M, Al-Mohanna FA, Nutr Metab (Lond) 2012 9 1 58 10.1186/1743-7075-9-58
26. Fats and fatty acids in human nutrition. Report by an expert committee. FAO Food and Nutrition paper91 2008 http://www.fao.org/docrep/013/i1953e/ i1953e00.pdf
27. The intake of high fat diet with different trans fatty acid levels differentially induces oxidative stress and non alcoholic fatty liver disease (NAFLD) in rats. Dhibi M, Brahmi F, Mnari A, Houas Z, Chargui I, Bchir L, Gazzah N, Alsaif MA, Hammami M, Nutr Metab (Lond) 2011 8 1 65 10.1186/1743-7075-8-65
28. Diet, nutrition and modulation of genomic expression in fetal origins of adult disease. Jackson AA, Burdge GC, Lillicrop KA, J Nutrigenet Nutrigenomics 2010 3 4-6 192 208 21474951
29. Development of metabolic systems. Grove KL, Grayson BE, Glavas MM, Xiao XQ, Smith MS, Physiol Behav 2005 86 646 660 10.1016/j.physbeh.2005.08.063 16289141 (Pubitemid 41728983)
30. Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat. Collison KS, Maqbool ZM, Inglis AL, Makhoul NJ, Saleh SM, Bakheet RH, Al-Johi MA, Al-Rabiah RK, Zaidi MZ, Al-Mohanna FA, Obesity (Silver Spring) 2010 8 6 1122 1134
31. Fourteenth Report of the Joint FAO/WHO Expert Committee on Food Additives FAO Nutrition Meetings Report Series No. 48, WHO Technical Report Series, No. 462. 1971 15
32. Tschanz C, Butchko HH, Stargel WW, Kotsonis FN, The Clinical Evaluation of a Food Additive: Assessment of Aspartame Boca Raton: CRC Press 1996 308
33. Homeostasis model assessment: insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations in man. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, Diabetologia 1985 28 412 419 10.1007/BF00280883 3899825 (Pubitemid 15018832)
34. A model-based background adjustment for oligonucleotide expression arrays. Wu ZL, Inizarry RA, Gentleman R, Martinez-Murillo F, Spencer F, J Am Stat Assoc 2004 99 909 917 10.1198/016214504000000683 (Pubitemid 39665934)
35. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Benjamini Y, Hochberg Y, J Royal Stat Soc Series B (Methodological) 1995 57 1 289 300
36. DAVID: database for annotation, visualization, and integrated discovery. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA, Genome Biol 2003 4 5 3 10.1186/gb-2003-4-5-p3 12734009
37. The utility of fasting glucose for detection of prediabetes. Cheng C, Kushner H, Falkner BE, Metabolism 2006 55 4 434 438 10.1016/j.metabol.2005.10. 003 16546472
38. Gender dimorphism in aspartame-induced impairment of spatial cognition and insulin sensitivity. Collison KS, Makhoul NJ, Zaidi MZ, Saleh SM, Andres B, Inglis A, Al-Rabiah R, Al-Mohanna FA, PLoS One 2012 7 4 31570 10.1371/journal.pone.0031570 22509243
39. Leaky beta-oxidation of a trans-fatty acid: incomplete beta-oxidation of elaidic acid is due to the accumulation of 5-trans-tetradecenoyl-CoA and its hydrolysis and conversion to 5-trans-tetradecenoylcarnitine in the matrix of rat mitochondria. Yu W, Liang X, Ensenauer RE, Vockley J, Sweetman L, Schulz H, J Biol Chem 2004 279 50 52160 52167 10.1074/jbc.M409640200 15466478 (Pubitemid 39656589)
40. Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance. Hammarstedt A, Jansson PA, Wesslau C, Yang X, Smith U, Biochem Biophys Res Commun 2003 301 578 582 10.1016/S0006-291X(03)00014-7 12565902 (Pubitemid 36279280)
41. Adipocyte differentiation, from fibroblast to endocrine cell. Gregoire FM, Exp Biol Med 2001 226 11 997 1002
42. Gene expression profiling of the short-term adaptive response to acute caloric restriction in liver and adipose tissues of pigs differing in feed efficiency. Lkhagvadorj S, Qu L, Cai W, Couture OP, Barb CR, Hausman GJ, Nettleton D, Anderson LL, Dekkers JC, Tuggle CK, Am J Physiol Regul Integr Comp Physiol 2010 298 2 494 R507 10.1152/ajpregu.00632.2009 19939971
43. Comparative analysis of the human hepatic and adipose tissue transcriptomes during LPS-induced inflammation leads to the identification of differential biological pathways and candidate biomarkers. Szalowska E, Dijkstra M, Elferink MG, Weening D, de Vries M, Bruinenberg M, Hoek A, Roelofsen H, Groothuis GM, Vonk RJ, BMC Med Genomics 2011 4 71 10.1186/1755-8794-4-71 21978410
44. Unconventional microarray design reveals the response to obesity is largely tissue specific: analysis of common and divergent responses to diet-induced obesity in insulin-sensitive tissues. Lee RK, Hittel DS, Nyamandi VZ, Kang L, Soh J, Sensen CW, Shearer J, Appl Physiol Nutr Metab 2012 37 2 257 268 10.1139/h11-159 22452611
45. Acetyl-CoA carboxylase beta gene is regulated by sterol regulatory element-binding protein-1 in liver. Oh SY, Park SK, Kim JW, Ahn YH, Park SW, Kim KS, J Biol Chem 2003 278 31 28410 28417 10.1074/jbc.M300553200 12764144 (Pubitemid 36935742)
46. Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription. Zhao LF, Iwasaki Y, Zhe W, Nishiyama M, Taguchi T, Tsugita M, Kambayashi M, Hashimoto K, Terada Y, Endocr J 2010 57 4 317 324 10.1507/endocrj.K09E-298 20139635
47. Expression of the thermogenic nuclear hormone receptor coactivator PGC-1α is reduced in the adipose tissue of morbidly obese subjects. Vidal-Puig A, O'Rahilly S, Int J Obes Relat Metab Disord 2004 28 176 179 10.1038/sj.ijo.0802482 14557831 (Pubitemid 38142007)
48. Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD). Yoneda M, Hotta K, Nozaki Y, Endo H, Uchiyama T, Mawatari H, Iida H, Kato S, Hosono K, Fujita K, Yoneda K, Takahashi H, Kirikoshi H, Kobayashi N, Inamori M, Abe Y, Kubota K, Saito S, Maeyama S, Wada K, Nakajima A, BMC Gastroenterol 2008 8 27 10.1186/1471-230X-8-27 18588668 (Pubitemid 352025048)
49. Transcriptional control of mitochondrial biogenesis; the central role of PGC-1α Ventura-Clapier R, Garnier A, Veksler V, Cardioovascular Res 2008 79 208 217 10.1093/cvr/cvn098 (Pubitemid 351951611)
50. Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. Crunkhorn S, Dearie F, Mantzoros C, Gami H, da Silva WS, Espinoza D, Faucette R, Barry K, Bianco AC, Patti ME, J Biol Chem 2007 282 21 15439 15450 10.1074/jbc.M611214200 17416903 (Pubitemid 47093279)
51. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Barrès R, Osler ME, Yan J, Rune A, Fritz T, Caidahl K, Krook A, Zierath JR, Cell Metab 2009 10 3 189 198 10.1016/j.cmet.2009.07.011 19723495
52. Monosodium glutamate-induced damage in liver and kidney: a morphological and biochemical approach. Ortiz GG, Bitzer-Quintero OK, Zárate CB, Rodríguez-Reynoso S, Larios-Arceo F, Velázquez-Brizuela IE, Pacheco-Moisés F, Rosales-Corral SA, Biomed Pharmacother 2006 0 2 86 91
53. Long term effect of monosodium glutamate in liver of albino mice after neo-natal exposure. Bhattacharya T, Bhakta A, Ghosh SK, Nepal Med Coll J 2011 13 1 11 16 21991693
54. Amelioration of monosodium glutamate-induced hepatotoxicity by vitamin C. Ibrahim MA, Buhari GO, Aliyu AB, Yunusa I, Bisalla M, Eur J Sci Res 2011 60 1 159 165
55. Effect of vitamin E on monosodium glutamate induced hepatotoxicity and oxidative stress in rats. Onyema OO, Farombi EO, Emerole GO, Ukoha AI, Onyeze GO, Indian J Biochem Biophys 2006 43 1 20 24 16955747 (Pubitemid 44475383)
56. Monosodium glutamate-induced oxidative damage and genotoxicity in the rat: modulatory role of vitamin C, vitamin E and quercetin. Farombi EO, Onyema OO, Hum Exp Toxicol 2006 25 5 251 259 10.1191/0960327106ht621oa 16758767 (Pubitemid 43828796)
57. Methanol poisoning and formate oxidation in nitrous oxide-treated rats. Eells JT, Makar AB, Noker PE, Tephly TR, J Pharmacol Exp Ther 1981 217 1 57 61 7205659 (Pubitemid 11103823)
58. Metabolic regulation by p53. Maddocks ODK, Vousden KH, J Mol Med 2011 89 237 245 10.1007/s00109-011-0735-5 21340684
59. Guardian of corpulence: a hypothesis on p53 signaling in the fat cell. Bazuine M, Stenkula KG, Cam M, Arroyo M, Cushman SW, Clin Lipidol 2009 4 2 231 243 10.2217/clp.09.2 20126301
60. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. Roth J, Dobbelstein M, Freedman DA, Shenk T, Levine AJ, EMBO J 1998 17 2 554 564 10.1093/emboj/17.2.554 9430646 (Pubitemid 28045495)
61. A high-throughput screen measuring ubiquitination of p53 by human mdm2. Murray MF, Jurewicz AJ, Martin JD, Ho TF, Zhang H, Johanson KO, Kirkpatrick RB, Ma J, Lor LA, Thrall SH, Schwartz B, J Biomol Screen 2007 12 8 1050 1058 10.1177/1087057107308556 17989425 (Pubitemid 350179699)
62. Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis. Garcés C, Ruiz-Hidalgo MJ, Font de Mora J, Park C, Miele L, Goldstein J, Bonvini E, Porrás A, Laborda J, J Biol Chem 1997 272 47 29729 29734 10.1074/jbc.272.47.29729 9368042 (Pubitemid 27508067)
63. Therapeutic approaches to modulating Notch signaling: current challenges and future prospects. Groth C, Fortini ME, Semin Cell Dev Biol 2012 23 4 465 472 10.1016/j.semcdb.2012.01.016 22309842
64. Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner. Pajvani UB, Shawber CJ, Samuel VT, Birkenfeld AL, Shulman GI, Kitajewski J, Accili D, Nat Med 2011 172 8 961 967
65. Disruption of Notch1 induces vascular remodeling, intussusceptive angiogenesis, and angiosarcomas in livers of mice. Dill MT, Rothweiler S, Djonov V, Hlushchuk R, Tornillo L, Terracciano L, Meili-Butz S, Radtke F, Heim MH, Semela D, Gastroenterology 2012 142 4 967 977 e2 10.1053/j.gastro.2011.12.052 22245843